Goodwin Biotechnology Inc. (GBI), a subsidiary of Wallace Pharmaceuticals Pvt. Ltd. is a biological contract manufacturing organization that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. Its core services include cell culture, purification, bioconjugation, biosimilars, aseptic filling and finishing and cGMP manufacturing. It also offers a range of mammalian cell culture development and manufacturing services. The company’s support services include assay development, quality control, quality assurance, regulatory support and translational medicine and consulting USA.